World News: 12:57 GMT Wednesday 15th May 2019. [BioPorto A/S via Globe Newswire via SPi World News]
BioPorto AS BioPortotoday that the company has submitted an application to the US Food and Drug Administration FDA for regulatory of The NGAL Test in the US for risk assessment of acute kidney injury AKI”)...
Globe Newswire: 12:57 GMT Wednesday 15th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.